• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ascentage Pharma Group International - American Depository Shares (NQ:AAPG)

    18.74 -1.66 (-8.14%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 12,127
    Open 19.25
    Bid (Size) 18.00 (1,000)
    Ask (Size) 19.07 (500)
    Prev. Close 20.40
    Today's Range 18.54 - 19.25
    52wk Range 16.36 - 48.45
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire

    Performance

    YTD
    -28.9%
    -28.9%
    1 Month
    +9.7%
    +9.7%
    3 Month
    -31.6%
    -31.6%
    6 Month
    -30.7%
    -30.7%
    1 Year
    -52.7%
    -52.7%

    More News

    Read More
    News headline image
    Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma to Participate in Three Upcoming Investor Conferences
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma to Participate in Three Upcoming Investor Conferences
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday ↗
    Via Benzinga
    News headline image
    Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 20, 2025 ↗
    Via Benzinga
    News headline image
    US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns' ↗
    Via Benzinga
    Topics Artificial Intelligence Government
    News headline image
    Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday ↗
    Via Benzinga
    News headline image
    Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire
    News headline image
    Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax
    From ASCENTAGE PHARMA GROUP INTERNATIONAL
    Via GlobeNewswire

    Frequently Asked Questions

    Is Ascentage Pharma Group International - American Depository Shares publicly traded?
    Yes, Ascentage Pharma Group International - American Depository Shares is publicly traded.
    What exchange does Ascentage Pharma Group International - American Depository Shares trade on?
    Ascentage Pharma Group International - American Depository Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Ascentage Pharma Group International - American Depository Shares?
    The ticker symbol for Ascentage Pharma Group International - American Depository Shares is AAPG on the Nasdaq Stock Market
    What is the current price of Ascentage Pharma Group International - American Depository Shares?
    The current price of Ascentage Pharma Group International - American Depository Shares is 18.74
    When was Ascentage Pharma Group International - American Depository Shares last traded?
    The last trade of Ascentage Pharma Group International - American Depository Shares was at 07/17/26 03:59 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.